title: The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes.
abstract: OBJECTIVE
  The role of statin use in the treatment of acute coronary syndromes (ACS) is not clear. The aim of our study was to evaluate the role of statins in ACS.
  
  
  METHODS
  Using data from the Acute Myocardial Infarction in Switzerland (AMIS Plus) Project, we compared the effects of chronic statin use, statin therapy after admission and no statin therapy on presentation mode and outcomes in ACS.
  
  
  RESULTS
  Available data from the period 2001-2006 including 11,603 patients were analyzed. Major cardiac event rates and in-hospital mortality were more common in statin-naive patients compared to patients who received statins.
  
  
  CONCLUSIONS
  Our results support the importance of statin treatment in ACS. Chronic statin therapy seems to alter the initial presentation of ACS but it is questionable whether it provides an additional effect on early outcomes compared to the establishment of statin therapy after admission in statin-naive patients.
authors.affiliation: Department of Cardiology, Kantonsspital Luzern, Luzern, Switzerland.
authors.forename: F
authors.initials: F
authors.lastname: Cuculi
authors.forename: D
authors.initials: D
authors.lastname: Radovanovic
authors.forename: F R
authors.initials: FR
authors.lastname: Eberli
authors.forename: J C
authors.initials: JC
authors.lastname: Stauffer
authors.forename: O
authors.initials: O
authors.lastname: Bertel
authors.forename: P
authors.initials: P
authors.lastname: Erne
mesh_terms: D054058:Acute Coronary Syndrome / Q000401:mortality / Q000517:prevention & control*; D000368:Aged; D016009:Chi-Square Distribution; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D012307:Risk Factors; D013557:Switzerland / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors